Today, we will be looking into the latest research and clinical trials focused on actinic keratosis in adults. The following list has been carefully curated by evaluating the ongoing phase 3 trials for actinic keratosis, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject to change. This […]
Read MoreWelcome to the latest edition of our Guidelines+ Monographs Series. In this installment, we will delve into the medication fluticasone furoate, umeclidinium, and vilanterol, marketed under the brand name Trelegy Ellipta by GlaxoSmithKline. Trelegy Ellipta is a combination of fluticasone furoate, an inhaled corticosteroid (ICS); umeclidinium, an anticholinergic; and vilanterol, a long-acting beta2-adrenergic agonist (LABA) indicated […]
Read More
The American Academy of Child and Adolescent Psychiatry (AACAP) Annual Meeting was held in Seattle, Washington from October 14-19, 2024. This prestigious event serves as the largest gathering of child and adolescent psychiatrists globally, providing a valuable opportunity to engage with and learn from peers and colleagues from over 60 countries. The AACAP 2024 Annual […]
Read More
Today, we will be looking into the latest research and clinical trials focused on both uncomplicated and complicated urinary tract infections (UTIs) in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for UTI, specifically targeting adults in the United States. Please note that the dates provided are approximate […]
Read More
Sport-related concussion (SRC) is a prevalent injury in both recreational and organized sports. Over the past few decades, there has been significant advancement in our scientific comprehension of SRC, leading to the establishment of clinical recommendations for its diagnosis, assessment, and management. As the need for knowledgeable healthcare professionals to deliver evidence-based care for athletes […]
Read More
Among all women in the United States, breast cancer is the second most common cancer and the second leading cause of cancer-related deaths. In 2023, an estimated 43,170 women lost their lives to breast cancer. The incidence of breast cancer has been gradually increasing among women aged 40 to 49 years from 2000 to 2015, […]
Read More
As we prepare for the National Immunization Awareness Month 2024 and upcoming autumn season, we will be conducting a thorough review of the United States Immunization Schedules for both Adults and Children. These crucial recommendations are released annually by the Centers for Disease Control and Prevention (CDC). They offer essential guidance on the recommended schedules […]
Read More
Our Guidelines Rundown Series continues with a new article that delves into the topic of breastfeeding in support of National Breastfeeding Month 2024. To provide guidance and clinical decision-making support on the matter, the Academy of Breastfeeding Medicine has published a comprehensive set of guidelines that address various aspects of breastfeeding, such as nutrition, supplements, […]
Read More
Today, we will be looking into the latest research and clinical trials focused on respiratory syncytial virus (RSV) immunization in adults. The following list has been carefully curated by evaluating the ongoing Phase 3 trials for RSV vaccinations, specifically targeting adults in the United States. Please note that the dates provided are approximate and subject […]
Read More
In this post, we will be taking a closer look at some of the most popular primary care/family medicine-related articles recently published across medical journals. Morbidity and Mortality of Hospital-Onset SARS-CoV-2 Infections Due to Omicron Versus Prior Variants: A Propensity-Matched Analysis Is Prediabetes Overdiagnosed? Yes: A Patient-Epidemiologist’s Experience Is Prediabetes Overdiagnosed? No: A Clinician’s Perspective […]
Read More